This Immunology eBook looks at the growing importance of immune research, providing insights into how it can deepen our understanding of disease, improve diagnostics, and support therapeutic development.
Designed for researchers, clinicians, and life science professionals, this edition explores how immune responses are measured, interpreted, and modulated using a combination of biomarker analysis, molecular biology, and emerging therapeutic strategies.
From identifying reliable indicators of immune activation to examining how the gut microbiome influences cancer development and how disrupted iron levels may contribute to long COVID, the eBook highlights the role of immune dysregulation across both acute and chronic conditions.
It also explores the growing importance of biomarkers in clinical and research settings, including periostin in allergic diseases and the clinical measurement of soluble immune receptors such as sIL-2R in diagnostic laboratories, alongside investigations into rare but significant immune-mediated events such as vaccine-induced thrombosis.
Overall, this eBook demonstrates how advances in biomarker discovery, mechanistic insight, and therapeutic innovation are strengthening the field of immunology and supporting improved outcomes across a wide range of diseases.
About IBL International GmbH, Part of Tecan Group
Specialty diagnostics to improve people’s lives and health
With decades of experience, Tecan has built a strong legacy of innovation in in vitro diagnostic testing for endocrinology, immunology and autoimmunity at IBL International, specializing in the development, manufacture and supply of immunoassays as well as LC-MS solutions. These products are designed and produced to the highest standards, providing diagnostics labs with reliable data and improved workflow efficiency to assess various health conditions from blood, urine, saliva and cerebrospinal fluid samples.
Tecan’s reagents portfolio includes a number of specialty diagnostic assays for endocrinology, immunology, neurotransmitters and autoimmunity in clinical diagnostics, along with key assays for the research segment, including BD-Tau LUM and NF Light®* ELISA.
By combining Tecan’s proven automation capabilities and leadership in instrumentation with IBL International’s specialized immunoassay and LC-MS portfolio, Tecan offers complete solutions tailored to the needs of specialty diagnostics and research laboratories. These offerings streamline lab workflows by boosting productivity, increasing efficiency and meeting high regulatory standards.
This focus on compliance helped Tecan respond quickly to the EU’s In Vitro Diagnostic Regulation (IVDR), becoming one of the first companies to achieve product certification under the new rules.
Tecan continues to invest in innovation, advancing its portfolio to address emerging diagnostic needs in both clinical and research settings. Recent developments include specialized assays such as BD-Tau, sIL-2R, SCCA2 and Periostin ELISAs, supporting neurology and immunology applications, as well as LC-MS based assays for vitamins B1 and B6, A and E testing in endocrinology.
Disclaimer:
Products manufactured and distributed by IBL International. Availability and regulatory status may vary across regions depending on local country specific registration. The combined use of the reagents, process script and instrument has to be validated individually on site by each laboratory.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.